Kevin E. Weddington

Array ( [id] => 6545950 [patent_doc_number] => 20020137752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria' [patent_app_type] => new [patent_app_number] => 09/996039 [patent_app_country] => US [patent_app_date] => 2001-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3739 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137752.pdf [firstpage_image] =>[orig_patent_app_number] => 09996039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507806 [patent_doc_number] => 06440951 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Method for treatment of diabetes' [patent_app_type] => B1 [patent_app_number] => 09/991650 [patent_app_country] => US [patent_app_date] => 2001-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5888 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440951.pdf [firstpage_image] =>[orig_patent_app_number] => 09991650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096634 [patent_doc_number] => 20020052324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor' [patent_app_type] => new [patent_app_number] => 09/989572 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3469 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052324.pdf [firstpage_image] =>[orig_patent_app_number] => 09989572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 741609 [patent_doc_number] => 07030132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'Method of improving bioavailability of orally administered drugs, a method of screening for enhancers of such bioavailability and novel pharmaceutical compositions for oral delivery of drugs' [patent_app_type] => utility [patent_app_number] => 09/988285 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6956 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030132.pdf [firstpage_image] =>[orig_patent_app_number] => 09988285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6291950 [patent_doc_number] => 20020055537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Use of inhibitors of the KQT1 channel and methods of controlling and treating diseases caused by helminths and ectoparasites' [patent_app_type] => new [patent_app_number] => 09/987809 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26582 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055537.pdf [firstpage_image] =>[orig_patent_app_number] => 09987809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329473 [patent_doc_number] => 20020198189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'New use' [patent_app_type] => new [patent_app_number] => 10/045319 [patent_app_country] => US [patent_app_date] => 2001-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18433 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198189.pdf [firstpage_image] =>[orig_patent_app_number] => 10045319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533419 [patent_doc_number] => 06410599 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Antiseptic compositions suitable for application to human tissue' [patent_app_type] => B1 [patent_app_number] => 09/993178 [patent_app_country] => US [patent_app_date] => 2001-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 17338 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410599.pdf [firstpage_image] =>[orig_patent_app_number] => 09993178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178098 [patent_doc_number] => 20020156098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis' [patent_app_type] => new [patent_app_number] => 09/985590 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20737 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156098.pdf [firstpage_image] =>[orig_patent_app_number] => 09985590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261772 [patent_doc_number] => 06664257 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-16 [patent_title] => 'Anti-mycobacterial compounds' [patent_app_type] => B2 [patent_app_number] => 09/993974 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6009 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664257.pdf [firstpage_image] =>[orig_patent_app_number] => 09993974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936740 [patent_doc_number] => 20020061918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Compositions and treatment for diabetic complications' [patent_app_type] => new [patent_app_number] => 10/003601 [patent_app_country] => US [patent_app_date] => 2001-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5421 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061918.pdf [firstpage_image] =>[orig_patent_app_number] => 10003601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5860053 [patent_doc_number] => 20060229368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'MEDICAL APPLICATION OF OXIDIZED MONOTERPENES' [patent_app_type] => utility [patent_app_number] => 10/016726 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5228 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229368.pdf [firstpage_image] =>[orig_patent_app_number] => 10016726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307912 [patent_doc_number] => 20020094971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Composition and method for the treatment of dysglucaemia' [patent_app_type] => new [patent_app_number] => 10/002417 [patent_app_country] => US [patent_app_date] => 2001-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7093 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094971.pdf [firstpage_image] =>[orig_patent_app_number] => 10002417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6657912 [patent_doc_number] => 20030078188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Modulators of insulin receptor activity' [patent_app_type] => new [patent_app_number] => 09/999762 [patent_app_country] => US [patent_app_date] => 2001-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 12837 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078188.pdf [firstpage_image] =>[orig_patent_app_number] => 09999762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414089 [patent_doc_number] => 06525034 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-25 [patent_title] => 'Clear personal care formulations containing quaternary ammonium compounds and other nitrogen-containing compounds' [patent_app_type] => B2 [patent_app_number] => 10/001123 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9013 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525034.pdf [firstpage_image] =>[orig_patent_app_number] => 10001123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1392161 [patent_doc_number] => 06544963 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-08 [patent_title] => 'Hemostatic agent' [patent_app_type] => B2 [patent_app_number] => 10/038427 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3023 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544963.pdf [firstpage_image] =>[orig_patent_app_number] => 10038427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131407 [patent_doc_number] => 20020077315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Bioadhesive antibacterial wound healing composition' [patent_app_type] => new [patent_app_number] => 09/978152 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5032 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077315.pdf [firstpage_image] =>[orig_patent_app_number] => 09978152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936693 [patent_doc_number] => 20020061893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Methods of use of quinolone compounds against anaerobic pathogenic bacteria' [patent_app_type] => new [patent_app_number] => 09/976323 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5639 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061893.pdf [firstpage_image] =>[orig_patent_app_number] => 09976323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6243238 [patent_doc_number] => 20020045649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Treatment of diabetes with thiazolidinedione and sulphonylurea' [patent_app_type] => new [patent_app_number] => 09/975883 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3482 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045649.pdf [firstpage_image] =>[orig_patent_app_number] => 09975883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 853052 [patent_doc_number] => 07378437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Drugs for diabetes' [patent_app_type] => utility [patent_app_number] => 10/398511 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11574 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378437.pdf [firstpage_image] =>[orig_patent_app_number] => 10398511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6079871 [patent_doc_number] => 20020081292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Anthelmintic composition' [patent_app_type] => new [patent_app_number] => 09/973361 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3126 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081292.pdf [firstpage_image] =>[orig_patent_app_number] => 09973361 [rel_patent_id] =>[rel_patent_doc_number] =>)